Structure

InChI Key ADYPXRFPBQGGAH-UMYZUSPBSA-N
Smile CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21.CS(=O)(=O)O
InChI
InChI=1S/C33H37N5O5.CH4O3S/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32;1-5(2,3)4/h3-6,8-11,17,21,23,25-27,34,42H,7,12-16,18H2,1-2H3,(H,35,39);1H3,(H,2,3,4)/t21-,23-,25-,26+,27+,32-,33+;/m1./s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C34H41N5O8S
Molecular Weight 679.8
AlogP 2.08
Hydrogen Bond Acceptor 6.0
Hydrogen Bond Donor 3.0
Number of Rotational Bond 4.0
Polar Surface Area 118.21
Molecular species NEUTRAL
Aromatic Rings 3.0
Heavy Atoms 43.0

Pharmacology

Action Mechanism of Action Reference
AGONIST Serotonin 1d (5-HT1d) receptor agonist DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference

Related Entries

Scaffolds

Parent
Mixture

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
23.38
Injury, poisoning and procedural complications
16.02
Vascular disorders
14.72
Nervous system disorders
9.52
Product issues
8.23
Respiratory, thoracic and mediastinal disorders
6.49
Gastrointestinal disorders
4.33
Skin and subcutaneous tissue disorders
4.33
Investigations
2.6

Cross References

Resources Reference
ChEBI 59756
ChEMBL CHEMBL1200517
FDA SRS 81AXN7R2QT
Guide to Pharmacology 121
KEGG C07798
PubChem 71171
SureChEMBL SCHEMBL40843
ZINC ZINC03978005